General Information of DTT (ID: TTJIH8Q)

DTT Name CCR5 messenger RNA (CCR5 mRNA) DTT Info
Gene Name CCR5

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Discontinued Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Maraviroc DMTL94F Human immunodeficiency virus infection 1C62 Approved [1]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
DdRNAi therapy rHIV7-shl-TAR-CCR5RZ, stem cells DM0I5LM Human immunodeficiency virus infection 1C62 Phase 1/2 [2]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
SCH-C DM8J9SF Human immunodeficiency virus infection 1C62 Discontinued in Phase 1 [3]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
viral macrophage inflammatory protein-II DMAXOPS Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Molecular cloning and radioligand binding characterization of the chemokine receptor CCR5 from rhesus macaque and human. Biochem Pharmacol. 2005 Dec 19;71(1-2):163-72.
2 Progress on RNAi-based molecular medicines. Int J Nanomedicine. 2012; 7: 3971-3980.
3 Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2005 Dec;49(12):4911-9.
4 A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science. 1997 Sep 12;277(5332):1656-9.